These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23257657)

  • 1. Anti-emetic effect of mosapride citrate hydrate, a 5-HT4 receptor agonist, on selective serotonin reuptake inhibitors (SSRIs)-induced emesis in experimental animals.
    Mine Y; Oku S; Yoshida N
    J Pharmacol Sci; 2013; 121(1):58-66. PubMed ID: 23257657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of mosapride citrate, a 5-HT4-receptor agonist, on gastric distension-induced visceromotor response in conscious rats.
    Seto Y; Yoshida N; Kaneko H
    J Pharmacol Sci; 2011; 116(1):47-53. PubMed ID: 21521930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual role of mosapride citrate hydrate on the gastric emptying evaluated by the breath test in conscious rats.
    Uchida M; Yamato S; Shimizu K; Amano T; Ariga H
    J Pharmacol Sci; 2013; 121(4):282-7. PubMed ID: 23514789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 5-HT4 receptor agonist mosapride attenuates NSAID-induced gastric mucosal damage.
    Fujisawa M; Murata T; Hori M; Ozaki H
    J Gastroenterol; 2010 Feb; 45(2):179-86. PubMed ID: 20012106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-emetic and emetic effects of erythromycin in Suncus murinus: role of vagal nerve activation, gastric motility stimulation and motilin receptors.
    Javid FA; Bulmer DC; Broad J; Aziz Q; Dukes GE; Sanger GJ
    Eur J Pharmacol; 2013 Jan; 699(1-3):48-54. PubMed ID: 23201066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological effects of the new gastroprokinetic agent mosapride citrate and its metabolites in experimental animals.
    Yoshida N; Omoya H; Kato S; Ito T
    Arzneimittelforschung; 1993 Oct; 43(10):1078-83. PubMed ID: 8267674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of effects of a selective 5-HT reuptake inhibitor versus a 5-HT4 receptor agonist on in vivo neurogenesis at the rectal anastomosis in rats.
    Kawahara I; Kuniyasu H; Matsuyoshi H; Goto K; Obata K; Misawa H; Fujii H; Takaki M
    Am J Physiol Gastrointest Liver Physiol; 2012 Mar; 302(6):G588-97. PubMed ID: 22194416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delineation of vagal emetic pathways: intragastric copper sulfate-induced emesis and viral tract tracing in musk shrews.
    Horn CC; Meyers K; Lim A; Dye M; Pak D; Rinaman L; Yates BJ
    Am J Physiol Regul Integr Comp Physiol; 2014 Mar; 306(5):R341-51. PubMed ID: 24430885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of 5-HT4 receptor agonist mosapride citrate on rectosigmoid sensorimotor function in patients with irritable bowel syndrome.
    Kanazawa M; Watanabe S; Tana C; Komuro H; Aoki M; Fukudo S
    Neurogastroenterol Motil; 2011 Aug; 23(8):754-e332. PubMed ID: 21615623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mosapride citrate, a 5-HT₄ receptor agonist, increased the plasma active and total glucagon-like peptide-1 levels in non-diabetic men.
    Aoki K; Kamiyama H; Masuda K; Togashi Y; Terauchi Y
    Endocr J; 2013; 60(4):493-9. PubMed ID: 23257734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of mosapride on prednisolone-induced gastric mucosal injury and gastric-emptying disorder in dog.
    Tsukamoto A; Ohno K; Maeda S; Nakashima K; Fukushima K; Fujino Y; Hori M; Tsujimoto H
    J Vet Med Sci; 2012 Sep; 74(9):1103-8. PubMed ID: 22531101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of 5-HT4 receptor agonist, mosapride citrate, on visceral hypersensitivity in a rat model.
    Lee JW; Sung KW; Lee OY; Lee SE; Sohn CI
    Dig Dis Sci; 2012 Jun; 57(6):1517-24. PubMed ID: 22427128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of effect of mosapride citrate and existing 5-HT4 receptor agonists on gastrointestinal motility in vivo and in vitro.
    Mine Y; Yoshikawa T; Oku S; Nagai R; Yoshida N; Hosoki K
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1000-8. PubMed ID: 9399969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 5-HT4 receptor agonist mosapride attenuates inflammation of reflux esophagitis.
    Zhuang ZH; Zou FM; Tang DP; Zhuang JY; Wei JJ; Yang LY
    Hepatogastroenterology; 2014; 61(129):115-9. PubMed ID: 24895805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacological effects of the gastroprokinetic agent mosapride citrate].
    Yoshida N
    Nihon Yakurigaku Zasshi; 1999 May; 113(5):299-307. PubMed ID: 10480157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of gastric acid on gastric emptying and gastric distension-induced pain response in rats--effects of famotidine and mosapride.
    Keto Y; Hirata T; Takemoto Y; Yamano M; Yokoyama T
    Neurogastroenterol Motil; 2012 Feb; 24(2):147-53, e88. PubMed ID: 22066725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prokinetic effect of mosapride citrate on horse gastric emptying rates.
    Okamura K; Sasaki N; Fukunaka M; Yamada H; Inokuma H
    J Vet Med Sci; 2008 Jun; 70(6):627-8. PubMed ID: 18628607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible involvement of peripheral serotonin 5-HT3 receptors in fluvoxamine-induced emesis in Suncus murinus.
    Fujiwara-Sawada M; Imanishi T; Yoshida A; Baba J
    J Pharm Pharmacol; 2003 Feb; 55(2):271-4. PubMed ID: 12631420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serotonin 5- HT4 receptor agonist (mosapride citrate)].
    Odaka T; Suzuki T; Seza A; Yamaguchi T; Saisho H
    Nihon Rinsho; 2006 Aug; 64(8):1491-4. PubMed ID: 16898619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mosapride stimulates human 5-HT
    Neumann J; Hesse C; Hofmann B; Gergs U
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Sep; 397(9):6705-6720. PubMed ID: 38498060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.